Cargando…

Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance

Prostate cancer is characterized by a high degree of heterogeneity, which poses a major challenge to precision therapy and drug development. In this review, we discuss how nongenetic factors contribute to heterogeneity of prostate cancer. We also discuss tumor heterogeneity and phenotypic switching...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Rongbin, Wang, Zongwei, Cheng, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068628/ https://www.ncbi.nlm.nih.gov/pubmed/35508696 http://dx.doi.org/10.1038/s41698-022-00272-w

Ejemplares similares

Tumor Progression, Microenvironments, and Therapeutics
por: Cheng, Hung-Chi, et al.
Publicado: (2022)

Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment
por: Li, Duocai, et al.
Publicado: (2023)

Immune mediators in the tumor microenvironment of prostate cancer
por: Dai, Jinlu, et al.
Publicado: (2017)

Tumor microenvironment signaling and therapeutics in cancer progression
por: Goenka, Anshika, et al.
Publicado: (2023)

The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance
por: Pu, Qian, et al.
Publicado: (2023)

Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment
por: Yu, Xudong, et al.
Publicado: (2023)

Role of tumor microenvironment in cancer progression and therapeutic strategy
por: Wang, Qingjing, et al.
Publicado: (2023)

Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
por: Cheng, Bisheng, et al.
Publicado: (2023)

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
por: Zhang, Aiping, et al.
Publicado: (2022)

Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer
por: Shee, Kevin, et al.
Publicado: (2018)

Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
por: Matos, Andreia, et al.
Publicado: (2021)

The role of tumor microenvironment in therapeutic resistance
por: Son, Beomseok, et al.
Publicado: (2016)

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
por: Wandmacher, Anna Maxi, et al.
Publicado: (2021)

Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment
por: Lv, Fangfang, et al.
Publicado: (2021)

Metformin inhibits the proliferation of benign prostatic epithelial cells
por: Wang, Zongwei, et al.
Publicado: (2017)

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
por: Chaudhary, Belal, et al.
Publicado: (2016)

Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
por: Li, Irene, et al.
Publicado: (2019)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
por: Albini, Adriana, et al.
Publicado: (2015)

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
por: Salemme, Vincenzo, et al.
Publicado: (2023)

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
por: Lenaerts, Anne, et al.
Publicado: (2015)

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy
por: Wang, Zongwei, et al.
Publicado: (2020)

ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
por: Xin, Shiyong, et al.
Publicado: (2023)

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy
por: Liu, Yini, et al.
Publicado: (2021)

Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance
por: He, Lin-feng, et al.
Publicado: (2023)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022)

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
por: Zhang, Zeda, et al.
Publicado: (2020)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression
por: Bordeleau, François, et al.
Publicado: (2023)

Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy
por: Zhang, Zicheng, et al.
Publicado: (2022)

Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer
por: Zhou, Hengfeng, et al.
Publicado: (2022)

Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression
por: Bian, Xiaojie, et al.
Publicado: (2019)

Spatiotemporal pH Heterogeneity as a Promoter of Cancer Progression and Therapeutic Resistance
por: Korenchan, David E., et al.
Publicado: (2019)

MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo
por: Xie, Yingqiu, et al.
Publicado: (2016)

CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
por: Jin, Jiakang, et al.
Publicado: (2021)

Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
por: Shinkawa, Tomohiko, et al.
Publicado: (2022)

Understanding heterogeneous tumor microenvironment in metastatic melanoma
por: Yan, Yiyi, et al.
Publicado: (2019)

Metabolism drives macrophage heterogeneity in the tumor microenvironment
por: Li, Shasha, et al.
Publicado: (2022)

Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
por: Hass, Ralf, et al.
Publicado: (2020)

The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment
por: Zhou, Daoying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_61s4rjim96gk4cgopvaebqep30